MedTrace Logo

Project Resurgence Communication Trial

NCT04418947 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 11120

Last updated 2021-10-28

Study results available
· View outcomes & findings →

Summary

Randomized, double-blind, of standard of care vs additional communication and factorial design of intervention letter vs. control letter and EHR vs mail delivery mechanism in patients who canceled visits and did not reschedule over a 90 day period starting March 9, 2020.

Conditions

  • Communication Research

Interventions

OTHER

Communication type

Control letter vs. intervention letter

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
FACTORIAL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-15
Primary Completion
2020-07-17
Completion
2020-07-17

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04418947 on ClinicalTrials.gov